Novo Nordisk has said it will invest DKK 3.2 billion (€432 million) in a manufacturing plant in Ireland that will be used to produce its "current and future" GLP-1 agonist-based therapies for diseases ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Pharmaceutical company Novo Nordisk has announced a €430m expansion of its manufacturing operation in Athlone which will see it produce the tablet form of its weight loss drug Wegovy. It was reported ...

Weight-loss drug pioneer Novo Nordisk will invest €432 million in upgrading its Athlone plant to produce the tablet form of its Wegovy therapy. The company said the Irish tabletting facility would ...

Bagsværd, Denmark, 2 March 2026 – Novo Nordisk today announced an investment of 432 million euro (approx. DKK 3.2 billion) in its facility in Monksland, Athlone, Ireland. This tabletting facility will ...

South Africa runs the world’s largest antiretroviral (ARV) treatment programme, with about eight million people on ARVs and a R15.5 billion tender to keep them medicated. A cornerstone of that tender ...

When formulation scientists in the lab want to develop new drug products, they typically use small equipment to make tablets either by lack of powder available, cost of API or for ease of use. What ...

The impact of granule densification in high-shear wet granulation on tabletting and product performance was investigated, at pharmaceutical production scale. Product performance criteria need to be ...